Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 1, 2000, Pages 49-54

  Ipt, Clemen ^a   Thompson, Henry J ^b   Ganther, Howard E ^c  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; SELENIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BROMODEOXYURIDINE; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; COLORING AGENTS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; CYSTEINE; ENZYME INHIBITORS; FEMALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICROTUBULE-ASSOCIATED PROTEINS; ORGANOSELENIUM COMPOUNDS; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; TUMOR SUPPRESSOR PROTEINS;

EID: 0342948959     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Abdullaev, F. I., and Frenkel, G. D. Time-course of inhibition of cellular nucleic acid synthesis by selenite. J. Inorg. Biochem., 55: 113-121, 1994.
2. Lu, J., Jiang, C., Kaeck, M, Ganther, H., Vadhanavikit, S., Ip, C., and Thompson, H. Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem. Pharmacol., 50: 213-219, 1995.
3. Lu, J., Pei, H., Ip, C., Lisk, D. J., Ganther, H., and Thompson, H. J. Effect of an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention. Carcinogenesis (Lond.), 17: 1903-1907, 1996.
4. Sinha, R., Said, T. K., and Medina, D. Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. Cancer Lett., 107: 277-284, 1996.
5. Kaeck, M., Lu, J., Strange, R., Ip, C., Ganther, H. E., and Thompson, H. J. Differential induction of growth arrest inducible genes by selenium compounds. Biochem. Pharmacol., 53: 921-926, 1997.
6. Sinha, R., and Medina, D. Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells. Carcinogenesis (Lond.). 18: 1541-1547, 1997.
7. Redman, C., Scott, J. A., Baines, A. T., Basye, J. L., Clark, L. C., Calley, C., Roe, D., Payne, C. M., and Nelson, M. A. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett., 125: 103-110, 1998.
8. Thompson, H. J., Wilson, A., Lu, J., Singh, M., Jiang, C., Upadhyaya, P., El-Bayoumy, K., and Ip, C. Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis (Lond.), 15: 183-186, 1994.
9. Ronai, Z., Tillotson, J. K., Traganos, F., Darzynkiewicz, Z., Conaway, C. C., Upadhyaya, P., and El-Bayoumy, K. Effects of organic and inorganic selenium compounds on rat mammary tumor cells. Int. J. Cancer, 63: 428-434, 1995.
10. Lu, J., Jiang, C., Kaeck, M., Ganther, H., Ip. C., and Thompson, H. Cellular and metabolic effects of triphenylselenonium chloride in a mammary cell culture model. Carcinogenesis (Lond.), 16: 513-517, 1995.
11. Ip, C. Lessons from basic research in selenium and cancer prevention. J. Nutr., 128: 1845-1854, 1998.
12. Ip. C., Hayes, C., Budnick, R. M., and Ganther, H. E. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res., 51: 595-600, 1991.
13. Ip. C., and Ganther, H. E. Comparison of selenium and sulfur analogs in cancer prevention. Carcinogenesis (Lond.), 13: 1167-1170, 1992.
14. Vadhanavikit, S., Ip, C., and Ganther, H. E. Metabolites of sodium selenite and methylated selenium compounds administered at cancer chemoprevention levels in the rat. Xenobiotica, 23: 731-745, 1993.
15. Ip, C., Zhu, Z., Thompson, H. J., Lisk, D., and Ganther, H. E. Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat. Anticancer Res., 19: 2875-2880, 1999.
16. Ip, C., Thompson, H., and Ganther, H. Activity of triphenylselenonium chloride in mammary cancer prevention. Carcinogenesis (Lond.), 15: 2879-2882, 1994.
17. Ip, C., Lisk, D. J., Ganther, H., and Thompson, H. J. Triphenylselenonium and diphenylselenide in cancer chemoprevention: comparative studies of anticarcinogenic efficacy, tissue selenium levels and excretion profile. Anticancer Res., 17: 3195-3200, 1997.
18. Ip, C., Thompson, H., and Ganther, H. E. Cytostasis and cancer chemoprevention: investigating the action of triphenylselenonium chloride in in vivo models of mammary Carcinogenesis. Anticancer Res., 18: 9-12, 1998.
19. Ip, C., Lisk, D. J., and Ganther, H. E. Activities of structurally-related lipophilic selenium compounds as cancer chemopreventivc agents. Anticancer Res., 18: 4019-4026, 1998.
20. Ganther, H. E., and Lawrence, J. R. Chemical transformations of selenium in living organisms: improved forms of selenium for cancer prevention. Tetrahedron, 53: 12299-12310, 1997.
21. Nigan, S. N., and McConnell, W. B. Seleno amino compounds from Astragalus bisculcatus: isolation and identification of γ-L-glutamyl-Se-methylseleno-L-cysteine and Se-methylseleno-L-cysteine. Biochim. Biophys. Acta, 192: 185-190, 1969.
22. Cai, X. J., Block, E., Uden, P. C., Zhang, Z., Quimby, B. D., and Sullivan, J. J. Allium chemistry: identification of selenoamino acids in ordinary and selenium-enriched garlic, onion, and broccoli using gas chromatography with atomic emission detection. J. Agric. Food Chem., 43: 1754-1757, 1995.
23. Bird, S. M., Ge, H., Uden, P. C., Tyson, J. F., Block, E., and Denoyer, E. High-performance liquid chromatography of selenoamino acids and organo selenium compounds: speciation by inductively coupled plasma mass spectrometry. J. Chromatogr. A, 789: 349-359, 1997.
24. Ip, C., Lisk, D. J., and Thompson, H. Selenium-enriched garlic inhibits the early stage but not the late stage of mammary carcinogenesis. Carcinogenesis (Lond.), 17: 1979-1982, 1996.
25. Russo, J., Tay, L. K., and Russo, I. H. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res. Treat., 2: 5-73, 1982.
26. Thompson, H. J., McGinley, J. N., Wolfe, P., Singh, M., Steele, V. E., and Kelloff, G. J. Temporal sequence of mammary intraductal proliferations, ductal carcinomas in situ and adenocarcinomas induced by 1-methyl-1-nitrosourea in rats. Carcinogenesis (Lond.), 19: 2181-2185, 1998.
27. McCullagh, P., and Nelder, J. A. Generalized Linear Models, Ed. 2, Chapter 6. London: Chapman and Hall, 1989.
28. Zhu, Z., Jiang, W., and Thompson, H. J. Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis. Mol. Carcinog., 24: 241-245. 1999.
29. 1 cyclin-cdk protein kinase activity, is related to p21. Cell, 78: 67-74, 1994.
30. Kip1. Genes Dev., 11: 2335-2346, 1997.
31. Durand, B., Gao, F. B., and Raff, M. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of Oligodendrocyte differentiation. EMBO J., 16: 306-317, 1997.
32. Koyama, H., Raines, E. W., Bornfeldt, K. E., Roberts, J. M., and Ross, R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell, 87: 1069-1078, 1996.
33. Kip1. Cell. 85: 721-732, 1996.
34. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85: 707-720, 1996.
35. Kip1. Breast Cancer Res. Treat., 52: 29-41, 1998.
36. Lanfear, J., Fleming, J., Wu, L., Webster, G., and Harrison, P. R. The selenium metabolite selenodigluthione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis (Lond.), 15: 1387-1392, 1994.
37. Stewart, M. J., Davis, R. L., Walsh, L. P., and Pence, B. C. Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells (HT29). Cancer Lett., 117: 35-40, 1997.
38. Redman, C., Xu, M. J., Peng, Y-M., Scott, J. A., Payne, C., Clark, L. C., and Nelson, M. A. Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis (Lond.), 18: 1195-1202, 1997.
39. Samaha, H. S., Hamid, R., El-Bayoumy, K., Rao, C. V., and Reddy, B. S. The role of apoptosis in the modulation of colon carcinogenesis by dietary fat and by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Epidemiol. Biomark. Prev., 6: 699-704, 1997.